These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10932428)

  • 41. [Health Technology Assessment: conceptual framework and international perspective].
    Kuhn-Barrientos L
    Rev Med Chil; 2014 Jan; 142 Suppl 1():S11-5. PubMed ID: 24861174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact assessment of Iran's health technology assessment programme.
    Yazdizadeh B; Mohtasham F; Velayati A
    Health Res Policy Syst; 2018 Feb; 16(1):15. PubMed ID: 29471838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A content analysis of Health Technology Assessment programs in Latin America.
    Arellano LE; Reza M; Blasco JA; Andradas E
    Int J Technol Assess Health Care; 2009 Oct; 25(4):570-6. PubMed ID: 19845988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health technology assessment: decentralized and fragmented in the US compared to other countries.
    Perry S; Thamer M
    Health Policy; 1997 Jun; 40(3):177-98. PubMed ID: 10168751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health technology assessment in Finland.
    Mäkelä M; Roine RP
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():102-7. PubMed ID: 19500439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. INTEGRATE-HTA: THE PERSPECTIVE OF EUnetHTA.
    Lampe K; Schnell-Inderst P
    Int J Technol Assess Health Care; 2017 Jan; 33(5):605-608. PubMed ID: 28874222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
    Nachtnebel A; Mayer J; Erdös J; Lampe K; Kleijnen S; Schnell-Inderst P; Wild C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):291-9. PubMed ID: 26354129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defining the Value of Health Technologies in Latin America: Developments in Value Frameworks to Inform the Allocation of Healthcare Resources.
    Pichon-Riviere A; Garcia-Marti S; Oortwijn W; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2019 Jan; 35(1):64-68. PubMed ID: 30938278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of health technology assessment in China: New challenges.
    Chen Y; He Y; Chi X; Wei Y; Shi L
    Biosci Trends; 2018; 12(2):102-108. PubMed ID: 29760354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MOST IMPORTANT BARRIERS AND FACILITATORS REGARDING THE USE OF HEALTH TECHNOLOGY ASSESSMENT.
    Cheung KL; Evers SMAA; de Vries H; Hiligsmann M
    Int J Technol Assess Health Care; 2017 Jan; 33(2):183-191. PubMed ID: 28849758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
    Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model® in a pharmaceutical company.
    Ducournau P; Irl C; Tatt I; McCarvil M; Gyldmark M
    Int J Technol Assess Health Care; 2019 Jan; 35(1):10-16. PubMed ID: 30789111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integration of health technology assessment recommendations into organizational and clinical practice: A case study in Catalonia.
    Gagnon MP; Sánchez E; Pons JM
    Int J Technol Assess Health Care; 2006; 22(2):169-76. PubMed ID: 16571192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A regulatory governance perspective on Health Technology Assessment (HTA) in Sweden.
    Shah SM; Barron A; Klinger C; Wright JS
    Health Policy; 2014 May; 116(1):27-36. PubMed ID: 24655685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The history of health technology assessment in Australia.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():61-7. PubMed ID: 19500436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hospital-based health technology assessment (HTA) in Finland: a case study on collaboration between hospitals and the national HTA unit.
    Halmesmäki E; Pasternack I; Roine R
    Health Res Policy Syst; 2016 Apr; 14():25. PubMed ID: 27044400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Historical development of health technology assessment in Thailand.
    Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
    Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
    BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DEVELOPMENT OF THE ONTARIO DECISION FRAMEWORK: A VALUES BASED FRAMEWORK FOR HEALTH TECHNOLOGY ASSESSMENT.
    Krahn M; Miller F; Bayoumi A; Brooker AS; Wagner F; Winsor S; Giacomini M; Goeree R; Schünemann H; van der Velde G; Petersen S; Sikich N; Dhalla I
    Int J Technol Assess Health Care; 2018 Jun; 34(3):290-299. PubMed ID: 29987995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A DECADE OF HEALTH TECHNOLOGY ASSESSMENT IN POLAND.
    Lipska I; McAuslane N; Leufkens H; Hövels A
    Int J Technol Assess Health Care; 2017 Jan; 33(3):350-357. PubMed ID: 28720170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.